09.10.2020 • Product

Optimal Time-to-Market for Life-Saving Biopharmaceuticals

Rentschler provides the best solution to guarantee the success of its client’s project and meet clinical and commercial needs.

The company leverages its established know-how to evaluate the best production approach for its client’s molecule and offers tailor-made timelines for therapeutics. By accelerating timelines via economically attractive process options, it generates competitive advantages for its client’s product, without compromising quality or safety.

Rentschler’s best-in-class project management team ensures that needs are reflected in every detail of project design, planning and execution from the beginning. It couples this collaborative approach with its deep knowledge of regulatory affairs. This results in an unrivalled track record in successful audits and approvals from health authorities around the globe.

Rentschler’s website offers additional information about the company’s accelerated timelines, considering economically attractive process options.

Company

Logo:

Rentschler Biopharma SE

Erwin-Rentschler-Str. 21
88471 Laupheim
Germany

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.